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Abstract
Objective A number of studies have recently suggested Ep-
stein–Barr virus (EBV) involvement in the pathogenesis of
periodontitis. In this study, we investigated the association
between major periodontopathic bacteria Porphyromonas
gingivalis (P. gingivalis) and EBV in Japanese chronic peri-
odontitis (CP) patients.
Materials and methods A group of 25 patients with CP par-
ticipated in the study along with 13 individuals without peri-
odontitis. Subgingival samples were obtained with paper
points. Quantitative real-time polymerase chain reaction
(PCR) was used to detect EBV DNA and P. gingivalis.
Results In the CP patients, EBV DNA and P. gingivalis were
detected in both 80 % of sites with probing pocket depths
(PPD) of ≥5 mm and in 40 and 36 % of sites with PPD
≤3 mm, respectively. EBV DNA and P. gingivalis were detect-
ed in 50 and 27 % of the sites in periodontally healthy individ-
uals. Coexistence of EBV DNA and P. gingivalis was signifi-
cantly higher in the deeper PPD sites of CP patients (68%) than
in the PPD sites of the healthy controls (15 %) and shallow
PPD sites of CP patients (12 %). PCR-positive deeper PPD
sites of CP patients for EBV DNA and P. gingivalis range
between 3.74×103∼2.83×109 and 2.73×105∼6.65×109
(copies/ml), respectively.
Conclusion These results suggest an association between
EBV DNA, P. gingivalis, and CP in Japanese individuals.
Further studies are required to clarify this association; howev-
er, we believe that our enhanced understanding of the patho-
genesis of periodontal diseases involving viral infections will
lead to new treatments.
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Introduction
The pathogenesis of periodontitis is a multiple-step process
involving complex interactions between specific bacterial fac-
tors, host factors, and a variety of environmental factors.
Periodontitis is caused by specific periodontopathic bacteria,
and it is evident that the immune responses against bacterial
products and the subsequent production of proinflammatory
cytokines are important for tissue destruction of the periodon-
tium [1]. Bacterial plaque is considered to be the principal
etiological factor in the onset and progression of periodontitis
[2]. Porphyromonas gingivalis (P. gingivalis), Tannerella
forsythia, and Treponema denticola are related to clinical
parameters of chronic periodontitis, such as probing pocket
depth (PPD) and bleeding on probing (BOP), and
Aggregatibacter actinomycetemcomitans is associated with
aggressive periodontitis characterized by rapid alveolar bone
loss [3, 4]. In microbiological diagnosis of periodontal dis-
eases, the subgingival plaque is commonly used to detect and
quantify the bacterial species [5, 6]. Interestingly, herpes virus
has been suggested to be involved in the etiology of periodon-
tal diseases because bacterial activity does not adequately
explain the clinical characteristics of periodontal diseases [7].
Epstein–Barr virus (EBV) is an enveloped herpes virus
with double-stranded DNA that only infects humans. In
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addition, EBV is a ubiquitous virus that infects most individ-
uals by early adulthood [8]. In primary human infection, cell-
free EBV in saliva infects naive B lymphocytes, causing them
to become proliferating blasts [9]. It then establishes a latent
infection in those lymphocytes, which are largely nonpermis-
sive for virus replication [10]. Among immunocompromised
hosts, EBV is frequently reactivated and can induce infectious
mononucleosis, autoimmune diseases, several malignancies
such as Burkitt’s lymphoma, Hodgkin’s disease, nasopharyn-
geal carcinoma, and post-transplant lymphoproliferative dis-
orders [8–13].
Recently, a positive association has been reported between
periodontitis and EBV infection [14–16]. EBV DNA is fre-
quently detected in saliva, salivary glands, gingival crevicular
fluid, and gingival tissues [15, 17–23]. Higher levels of EBV
DNA have been detected in the saliva of patients with chronic
periodontitis or aggressive periodontitis [16, 17, 24]. More-
over, we demonstrated a relationship between microbial inter-
actions and the etiology of periodontal diseases and discov-
ered that P. gingivalis can induce EBV reactivation through
epigenetic regulation [25].
EBV replicates at salivary glands, oral mucosal membrane,
and nasopharyngeal epithelials [26, 27]. EBV DNA was de-
tected in the throat washings of 90 % of healthy adults and in
the saliva of 38 % of healthy children in Japan [27]. However,
no studies have evaluated the prevalence and quantitative of
EBV DNA in chronic periodontitis among the Japanese.
Therefore, the purpose of this study was to determine the
prevalence and quantitative analysis of EBV DNA and




Thirteen periodontally healthy individuals (mean±SD age
52.9±18.0) and 25 chronic periodontitis (CP) patients (mean
±SD age 54.2±13.8) were included in this study. They re-
ceived dental care at Nihon University Hospital School of
Dentistry atMatsudo, Japan. The Institutional Internal Review
and Ethics Board at the Nihon University School of Dentistry
at Matsudo approved the study (EC14-11-027-1). Written
informed consent was obtained from each study subject after
all procedures had been fully explained. CP patients were
defined as the presence of at least two sites with probing
pocket depth (PPD) ≥5 mm and attachment loss of more than
5 mm. A group of 13 individuals without periodontitis were
included as healthy controls (HC). Subjects showed no clini-
cal signs of gingival inflammation and attachment loss; more-
over, no detectable bone loss was confirmed through radio-
graphic examination and PPD ≤3 mm. All subjects were
systemically healthy and had no history of periodontal treat-
ment or any type of antibiotic therapy for at least 3 months
prior to the present study. A total of 50 subgingival plaque
samples were collected from two periodontal sites of PPD (≥5
and ≤3 mm) among 25 CP patients, and 26 subgingival plaque
samples were collected from two sites of PPD (≤3mm) among
13 periodontally healthy individuals. Before sampling,
supragingival plaque was removed with sterile cotton pellets.
Sterile paper points were then inserted to the sample site and
retained for 30 s (three times). The paper points were pooled in
microcentrifuge tubes and stored at −80 °C until DNA
extraction.
DNA extraction and real-time polymerase chain reaction
DNA extraction from the clinical samples was carried out
using High Pure Viral Nucleic Acid Kit according to the user
manual (Roche Applied Science, Mannheim, Germany). For
the quantitative detection of EBV DNA and P. gingivalis in
the samples, real-time polymerase chain reaction (PCR) was
used [5, 6]. DNA extracted from the cell lines AKATA and
P. gingivalis TDC60 were used as positive control [28, 29].
PCR was performed using the following primer sets: EBV
forward, 5′-CCTGGTCATCCTTTGCCA-3′; EBV reverse,
5′-TGCTTCGTTATAGCCGTAGT-3′; P. gingivalis forward,
5′-AGGCAGCTTGCCATACTGCG-3′; P. gingivalis reverse,
5′-ACTGTTAGCAACTACCGATGT-3′; GAPDH forward,
5′-GCACCGTCAAGGCTGAGAAC-3′; and GAPDH re-
verse, 5′-ATGGTGGTGAAGACGCCAGT-3′, using the
SYBR Premix Ex Taq in a TP800 thermal cycler dice real-
time system (Takara-bio, Tokyo, Japan). PCR products com-
prised 95 bp for EBV, 404 bp for P. gingivalis, and 142 bp for
GAPDH, respectively. The amplification reactions were per-
formed in a final volume of 25 μl 2× SYBR Premix Ex Taq
(12.5 μl), 0.4 μM forward and reverse primers (0.2 μl), and
50 ng complementary DNA (cDNA) (5 μl) and 10 ng cDNA
(1 μl) for GAPDH. To reduce variability between replicates,
PCR premixes, which contain all reagents except for cDNA,
were prepared and aliquoted into 0.2-ml Hi-8-tubes (TakaRa,
Tokyo, Japan). The thermal cycling conditions were 10 s at
95 °C and 40 cycles of 5 s at 95 °C and 30 s at 60 °C. Post-
PCR melting curves confirmed the specificity of single-target
amplification, and the expressions of EBV DNA and
P. gingivalis relative to GAPDH were determined. The dy-
namic range of the real-time PCR assays were determined
through serial dilution of DNA extracts either AKATA cells or
P. gingivalis TDC60 of the standards in the range of 1010∼101
copies per ml [28, 29].
Statistical analysis
Fisher’s exact probability test was used to determine whether
individual pathogens were associated with chronic
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periodontitis. P values <0.05 were considered statistically
significant.
Results
Characteristics of patients and clinical data are summarized in
Table 1. The average PPD (n=26) of the HC was 2.77±
0.43 mm. Among CP patients (n=25), the two periodontal
sites of PPD (≤3 and ≥5 mm) were 2.84±0.37 and 6.28±
1.28 mm, respectively. BOP was detected 3.8 % in HC and 4
or 72 % in shallow (≤3 mm) or deep PPD (≥5 mm) sites from
CP patients.
Table 2 describes clinical data and counts of EBV DNA
and P. gingivalis in the CP patients. Two PCR-positive peri-
odontal sites of PPD (≤3 and ≥5 mm) of CP patients for EBV
DNA range from 4.37×104∼9.13×106 copies/ml (≤3 mm)
and 3.74×103∼2.83×109 copies/ml (≥5 mm), and for
P. gingivalis were 3.97×106∼2.13×109 copies/ml (≤3 mm)
and 2.73×105∼6.65×109 copies/ml, respectively. Table 3
shows clinical data and counts of EBV DNA and P. gingivalis
in the HC. PCR-positive sites of PPD (≤3mm) of HC for EBV
DNA range from 1.27×104∼2.66×108 copies/ml and for
P. gingivalis were 4.16× 106∼6.62× 109 copies/ml,
respectively.
The occurrence frequencies of EBVDNA and P. gingivalis
in the HC and patients with CP are listed in Table 4. EBV
DNA was detected in 13 (50 %) periodontal pockets of HC
and in 10 (40 %) and 20 (80 %) of the shallow (≤3 mm) and
deeper PPD sites (≥5 mm) of patients with CP, respectively.
P. gingivalis was detected in 7 (27 %) periodontal pockets of
HC and in 9 (36%) and 20 (80%) of the shallow (≤3 mm) and
deeper PPD sites (≥5 mm) of CP patients, respectively. EBV
DNA and P. gingivalis were detected with higher frequencies
in deeper PPD sites of CP patients than in PPD sites of HC.
Additionally, EBV DNA and P. gingivalis were significantly
more frequent in deeper PPD sites than in shallow PPD sites of
CP patients. The occurrence frequency of EBV DNA (50 %)
was higher than P. gingivalis (27 %) in PPD sites of HC.
However, EBVDNA andP. gingivaliswere detected at almost
similar frequencies in shallow PPD sites (40 and 36 %) and in
deeper PPD sites (80 and 80%) of CP patients. Coexistence of
EBV DNA and P. gingivalis was significantly higher in the
deeper PPD sites of CP patients (68%) than in the PPD sites of
the HC (15 %) and shallow PPD sites of CP patients (12 %).
Discussion
Although bacteria play an essential role in the etiology of
periodontal disease, it has become increasingly clear that
herpes viruses, especially EBV, are involved in the etiology
of several types of periodontal disease because bacterial ac-
tivity alone does not adequately explain several clinical char-
acteristics of periodontal disease [7, 15]. In fact, a purely
bacterial cause of aggressive periodontitis does not explain
why the disease tends to develop bilaterally symmetric and
site-specific and why vertical bone resorption can advance at
one tooth while barely affecting the periodontium of an adja-
cent tooth sharing the interproximal space [7, 30]. Junctional
epithelial cells from the gingiva were infected with EBV, and
the EBV infection was significantly increased with disease
severity [31]. The results suggest that gingival epithelial cells
may serve as an oral reservoir of latent EBV-infected cells.
The results of this study reveal an association between EBV
DNA and deep PPD sites and, likewise, P. gingivalis and deep
PPD sites (≥5 mm) of CP lesions. Furthermore, EBV DNA
and P. gingivalis coexist in the deep PPD sites of CP patients
at high frequency (68 %). These results correlated with previ-
ous studies that showed statistically significant levels of EBV
DNA in CP patients compared with healthy individuals [15,
21]. Slots and his collaborators discoveredmore EBVDNA in
the gingival crevicular fluid and saliva of periodontal patients,
and the increase in EBV counts with increasing severity of
periodontitis lends substantial support to a periodontopathic
role of EBV [6, 20, 22–24]. The data showed that EBV DNA
was detected at ∼300-fold higher copy numbers in the PCR-
positive deep PPD compared to shallow PPD sites. Moreover,
P. gingivalis was detected at ∼3-fold higher copy numbers in
the PCR-positive deep PPD compared to shallow PPD sites, in
spite of having high EBV DNA and P. gingivalis-negative
shallow PPD sites among both patients with CP and HC
(Tables 2 and 3). These results suggest that high copy numbers
of EBV DNA and P. gingivalis may reflect the severity of
inflammation. In the previous report, range of counts in PCR-
positive sites of periodontitis patients and periodontally nor-
mal subjects for EBV DNA (positive %; 60 and 13 %) were
2.1×103∼8.3×108 and 2.4×103∼3.2×104 copies/ml, and for
P. gingivalis (positive %; 87 and 13 %) were 5×103∼1×1010
and 2.1×104∼3.1×106 copies/ml [6]. The results showed that
copy numbers of EBV DNA and P. gingivalis in the
Table 1 Characteristics of subjects and clinical data in this study
HC (13 healthy individuals) CP (25 CP patients)
Age 52.9±18.0 54.2±13.8
Males 2 (15 %) 8 (32 %)
Females 11 (85 %) 17 (68 %)
PPD 2.77±0.43 (n=26) 2.84±0.37 (≤3 mm; n=25)
6.28±1.28 (≥5 mm; n=25)
BOP 1 (3.8 %) (n=26) 1 (4 %) (≤3 mm; n=25)
18 (72 %) (≥5 mm; n=25)
HC healthy controls, CP chronic periodontitis
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1 Male 56 3 − ND ND 8 + 4.69×104 7.65×105
2 Male 57 3 − 1.09×106 ND 8 + 7.16×104 4.26×107
3 Female 58 3 − ND 2.13×109 6 − ND 2.86×108
4 Female 62 3 − 1.22×106 ND 7 + 8.85×105 2.46×106
5 Female 52 2 − 4.37×104 3.97×106 7 + 2.72×105 2.22×106
6 Female 40 3 − ND 4.10×107 6 + ND 1.29×107
7 Male 59 3 − ND ND 6 + 1.23×107 2.79×107
8 Female 29 3 − 9.13×106 ND 8 + 8.60×105 2.11×106
9 Female 63 3 − 4.20×105 8.95×106 5 − 1.05×106 1.71×107
10 Female 27 3 − 9.33×105 ND 5 − 3.70×107 ND
11 Female 63 3 − ND 7.75×107 8 + 3.06×104 2.21×107
12 Male 82 3 − 4.85×106 1.32×108 6 + 2.83×109 6.65×109
13 Male 58 3 − 2.89×106 ND 5 − 1.67×107 2.13×108
14 Female 49 3 − ND ND 6 + 3.74×103 1.09×108
15 Female 72 3 − ND ND 6 + 6.65×103 2.79×107
16 Female 39 2 − ND ND 5 + ND ND
17 Male 54 3 − ND 7.81×106 6 + 8.79×103 3.73×106
18 Female 42 3 − ND 1.33×108 10 + 4.93×104 1.15×109
19 Female 60 3 − ND ND 5 − 3.22×106 ND
20 Female 33 3 − ND 2.45×107 6 + 4.35×104 5.64×108
21 Male 49 3 − 7.96×105 ND 5 − 1.96×105 ND
22 Female 61 2 − ND ND 6 + ND 3.56×106
23 Male 79 2 − ND ND 6 + 1.72×104 1.64×108
24 Female 59 3 + 1.41×105 ND 6 + 1.21×104 2.73×105
25 Female 52 3 − ND ND 5 − ND ND
ND not detectable















1 Female 64 3 − ND ND 3 − ND ND
2 Female 72 3 − ND ND 3 − 1.30×107 ND
3 Female 72 3 − ND ND 3 − ND ND
4 Female 40 3 − 1.09×105 ND 3 − ND ND
5 Male 28 2 − ND ND 3 − ND ND
6 Female 26 2 − ND ND 3 − ND ND
7 Female 64 3 − 8.15×107 1.41×109 3 − 2.58×107 8.34×107
8 Female 64 3 − ND 6.62×109 3 − 2.20×106 ND
9 Female 46 3 − 2.66×108 ND 2 − 3.59×107 ND
10 Male 73 3 − 2.33×105 ND 3 − 1.27×104 5.96×108
11 Female 56 2 − 5.81×105 ND 2 + ND 1.61×107
12 Female 25 3 − 2.46×106 ND 2 − 2.55×106 ND
13 Female 58 3 − 2.56×105 4.16×106 3 − ND 9.17×106
ND not detectable
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periodontal lesions were almost the same as in our study
(Table 2); however, their copy numbers in the normal subjects
were lower compared to our data (Table 3). EBV DNA was
detected at higher rate in the PPD sites of HC (50 %) than in
the shallow PPD sites of CP (40 %). On the other hand,
P. gingivalis was detected at higher rate in the shallow PPD
sites of CP (36 %) than in the PPD sites of HC (27 %)
(Table 4). These results might be caused by higher latent
infection rate of healthy Japanese by EBV.
We have previously reported B cell marker CD19 immu-
nostaining showed that a large number of B cells had infiltrat-
ed into the gingival connective tissues of patients with peri-
odontitis [15]. And the results of in situ hybridization using
EBV-encoded small RNA (EBRE) showed a large number of
B cells in the same location that were EBER-positive [15].
Results suggest that EBV copy numbers in the subgingival
plaque samples may relate to the severity of inflammation and
the numbers of inflammatory cell infiltration in the gingiva.
The mechanisms of EBV reactivation and activated EBV
progressing to periodontal disease have not been determined.
Latent EBV in B cells can be reactivated to switch to lytic
replication. EBV reactivation can be induced in vitro by a
variety of stimuli, including 12-O-tetradecanoylphorbol-13-
acetate and anti-immunoglobulin, but a causal relationship
between a coinfection with EBV and periodontopathic bacte-
ria and the disruption of viral latency is not well understood.
We have previously reported that the culture supernatant from
P. gingivalis, which contains high concentrations of butyric
acid, inhibits histone deacetylase and thus increases histone
acetylation and transcriptional activity of the EBV BZLF1
gene, which encodes the master regulator protein (ZEBRA)
for the transition from latency to the lytic replication cycle
[25]. Given that regulation of the switch from latency to
reactivation is an initial key step in EBV infection, these
observations suggest that butyric acid-producing
periodontopathic bacteria, such as P. gingivalis, have the
potential to trigger EBV reactivation in the oral cavity of
infected individuals [25]. EBV-infected inflamed periodontal
sites tend to harbor elevated levels of periodontopathic bacte-
ria [15, 21, 23, 32]. Furthermore, bacterial and viral
coinfections were also reported more frequently in deep
periodontal pockets [14, 15, 21, 23]. EBV-1, EBV-2, and
P. gingivalis were detected in 72.5, 10, and 95 % of sites with
probing pocket depths ≥6 mm, respectively [21]. We also
reported that EBV and P. gingivalis were detected in 66 and
65 % of sites with probing pocket depths ≥5 mm, and EBV
DNA and P. gingivalis coinfection was found in 42 % of sites
with probing pocket depths ≥5 mm [15]. These observations
suggest that a “negative chain reaction” by EBV and
periodontopathic bacteria may contribute to the
etiopathogenesis of periodontitis [33].
In summary, we performed quantitative analysis of EBV
DNA and P. gingivalis in Japanese chronic periodontitis pa-
tients which to our knowledge is the first such attempt. EBV
DNA and P. gingivalis were detected in higher copy numbers
in PCR-positive deep PPD and showed a higher incidence of
the coexistence as compared to shallow PPD sites. Taking into
account that periodontopathic anaerobic bacteria may increase
the virulence of EBV via reactivation of EBV through butyric
acid, their suppression or eradication may become an effective
treatment to block EBV reactivation for early treatment or
prevention of chronic periodontitis.
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